Cargando…

Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC

PURPOSE: Previous studies suggest that stereotactic body radiation therapy (SBRT) is associated with higher toxicity rates for central lung tumors relative to peripheral tumors when using 3 fraction SBRT. The initial results from Radiation Therapy Oncology Group study 0813 suggest a safe toxicity pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnett, Andrea L.H., Mou, Benjamin, Owen, Dawn, Park, Sean S., Nelson, Katy, Hallemeier, Christopher L., Sio, Terence, Garces, Yolanda I., Olivier, Kenneth R., Merrell, Kenneth W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Thoracic Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460233/ https://www.ncbi.nlm.nih.gov/pubmed/31011688 http://dx.doi.org/10.1016/j.adro.2019.01.002

Ejemplares similares

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules
por: Owen, Dawn, et al.
Publicado: (2015)

Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung
por: Owen, Dawn, et al.
Publicado: (2015)

Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience
por: Yu, Nathan Y., et al.
Publicado: (2019)

Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non–small cell lung cancer
por: Breen, William G., et al.
Publicado: (2016)

Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors
por: Sio, Terence T., et al.
Publicado: (2014)

Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomes
por: Jethwa, Krishan R., et al.
Publicado: (2018)

Fatal Radiation Pneumonitis: Literature Review and Case Series
por: Keffer, Stephen, et al.
Publicado: (2019)

The intersegmental pulmonary vein is not always located on the intersegmental plane of the lung: Evaluation with 3-dimensional volume-rendering image reconstruction
por: Mimae, Takahiro, et al.
Publicado: (2022)

Feasibility study of a novel wireless localization technique using radiofrequency identification markers for small and deeply located lung lesions
por: Yutaka, Yojiro, et al.
Publicado: (2022)

Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive Impairments
por: Gandhidasan, Senthilkumar, et al.
Publicado: (2019)

Angiosarcoma of the Seminal Vesicle: A Case Report of Long-Term Survival Following Multimodality Therapy
por: Chang, Kenneth, et al.
Publicado: (2014)

Ultrasound location of ground-glass opacity during thoracoscopic surgery
por: Messina, Gaetana, et al.
Publicado: (2022)

Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial
por: Henke, Lauren E., et al.
Publicado: (2018)

SBRT for centrally localized NSCLC – What is too central?
por: Roesch, J., et al.
Publicado: (2016)

Use and Outcomes of SBRT for Early Stage NSCLC Without Pathologic Confirmation in the Veterans Health Care Administration
por: Wilkie, Joel R., et al.
Publicado: (2021)

Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes
por: Sood, Sumit S., et al.
Publicado: (2017)

Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancer
por: Lam, Miranda B., et al.
Publicado: (2018)

Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition
por: von Reibnitz, Donata, et al.
Publicado: (2018)

Increases in Serial Pretreatment (18)F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
por: Prionas, Nicolas D., et al.
Publicado: (2018)

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution
por: Yegya-Raman, Nikhil, et al.
Publicado: (2019)

Interobserver reliability in describing radiographic lung changes after stereotactic body radiation therapy
por: Kalman, Noah S., et al.
Publicado: (2018)

Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes
por: Zou, Zhenwei, et al.
Publicado: (2020)

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
por: Corradetti, Michael N., et al.
Publicado: (2019)

Segmentectomy versus lobectomy for inner-located small-sized early non-small-cell lung cancer
por: Tane, Shinya, et al.
Publicado: (2022)

A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer
por: Routman, David M., et al.
Publicado: (2019)

Neoadjuvant SBRT combined with immunotherapy in NSCLC: from mechanisms to therapy
por: Shi, Yanhong, et al.
Publicado: (2023)

Delays to surgery and worse outcomes: The compounding effects of social determinants of health in non–small cell lung cancer
por: Ashrafi, Arman, et al.
Publicado: (2023)

Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumors
por: Peng, Terrance, et al.
Publicado: (2022)

Surgical markup in lung cancer resection, 2015-2020
por: Robinson, Eric, et al.
Publicado: (2023)

Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer
por: Wang, Jennifer C., et al.
Publicado: (2022)

Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines
por: Peng, Terrance, et al.
Publicado: (2022)

Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
por: Ashrafi, Arman, et al.
Publicado: (2023)

Is wedge a dirty word? Demographic and facility-level variables associated with high-quality wedge resection
por: Collins, Micaela L., et al.
Publicado: (2023)

Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
por: Repka, Michael C., et al.
Publicado: (2017)

Safety of lung cancer surgery during COVID-19 in a pandemic epicenter
por: Villena-Vargas, Jonathan, et al.
Publicado: (2022)

Perimembrane Aurora-A Expression is a Significant Prognostic Factor in Correlation with Proliferative Activity in Non-Small-Cell Lung Cancer (NSCLC)
por: Ogawa, Eiji, et al.
Publicado: (2007)

Oesophageal IGRT considerations for SBRT of LA-NSCLC: barium-enhanced CBCT and interfraction motion
por: Woodford, Katrina, et al.
Publicado: (2021)

Stereotactic body radiation therapy for medically inoperable, clinically localized, urothelial carcinoma of the renal pelvis: A case report
por: Evans, Jaden D., et al.
Publicado: (2017)

Thoracoscopic S(4)a subsegmentectomy combined with wedge resections for treatment of metastatic tumors located at the intersection of the major and minor fissures
por: Obayashi, Kai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_93aescm402migu5keldfbeouf8